4565.T
4565.T
JP3431300007
NXERA PHARMA CO LTD
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
112.57B EUR
89.82B EUR
91.29B EUR
Enterprise Value
149.23B EUR
126.48B EUR
91.29B EUR
Valuation Multiples
Trailing P/E
--
--
--
Forward P/E
27.48x
--
--
Price to Sales
3.37x
--
--
Price to Book
1.74x
1.39x
--
EV/Revenue
4.46x
--
--
EV/EBITDA
197.92x
--
--
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
-5.19%
--
--
ende